F/m Emerald Life Sciences Innovation ETF LFSC

Morningstar Medalist Rating

Morningstar’s Analysis LFSC

Will LFSC outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

F/m Emerald Life Sciences Innovation ETF holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LFSC

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings54.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Replimune Group Inc

10.9313M
Healthcare

LivaNova PLC

8.0210M
Healthcare

Travere Therapeutics Inc Ordinary Shares

5.747M
Healthcare

Cogent Biosciences Inc

5.326M
Healthcare

Guardant Health Inc

4.475M
Healthcare

BillionToOne Inc Ordinary Shares - Class A

4.295M
Healthcare

Spyre Therapeutics Inc

4.225M
Healthcare

Corcept Therapeutics Inc

3.935M
Healthcare

Veradermics Inc

3.905M
Healthcare

United Therapeutics Corp

3.895M
Healthcare

Sponsor Center